Search research articles
Contact Us
Filters
Showing results (221-230 of 315) with videos related to
Page
of 32
Sort By:
International Journal of Cancer
|
February 19, 2016
A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapy
Cathy Eng, Alberto Bessudo, Lowell L Hart, et al.
International Journal of Clinical Oncology
|
September 1, 2025
Efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer: a FRESCO-2 subgroup analysis of patients enrolled in Japan
Daisuke Kotani, Takayuki Yoshino, Toshiki Masuishi, et al.
Oncotarget
|
November 7, 2014
The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal
Cathy Eng, George J Chang, Y Nancy You, et al.
JAMA Network Open
|
May 24, 2022
Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Review
Chan Shen, Daniel Tannenbaum, Robert Horn, et al.
American Journal of Clinical Oncology
|
March 31, 2016
Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy
In J Park, Y Nancy You, John M Skibber, et al.
American Journal of Clinical Oncology
|
October 19, 2016
Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation
Eleanor M Osborne, Cathy Eng, John M Skibber, et al.
Obstetric Medicine
|
July 18, 2022
Colorectal cancer during pregnancy or postpartum: Case series and literature review
Jane E Rogers, Terri L Woodard, Graciela Mn Gonzalez, et al.
Targeted Oncology
|
March 27, 2025
A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors
Cathy Eng, Nehal J Lakhani, Philip A Philip, et al.
Annals of Surgical Oncology
|
August 24, 2017
Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial Neoplasm
Tara L Sagebiel, Amr Mohamed, Aurelio Matamoros, et al.
Plos One
|
August 30, 2017
Clinical utility of circulating cell-free DNA in advanced colorectal cancer
Allan A Lima Pereira, Maria Pia Morelli, Michael Overman, et al.
Page
of 32
Search research articles
Search
Showing results (221-230 of 315) with videos related to
Sort By:
Page
of 32
International Journal of Cancer
|
February 19, 2016
A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapy
Cathy Eng, Alberto Bessudo, Lowell L Hart, et al.
International Journal of Clinical Oncology
|
September 1, 2025
Efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer: a FRESCO-2 subgroup analysis of patients enrolled in Japan
Daisuke Kotani, Takayuki Yoshino, Toshiki Masuishi, et al.
Oncotarget
|
November 7, 2014
The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal
Cathy Eng, George J Chang, Y Nancy You, et al.
JAMA Network Open
|
May 24, 2022
Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Review
Chan Shen, Daniel Tannenbaum, Robert Horn, et al.
American Journal of Clinical Oncology
|
March 31, 2016
Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy
In J Park, Y Nancy You, John M Skibber, et al.
American Journal of Clinical Oncology
|
October 19, 2016
Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation
Eleanor M Osborne, Cathy Eng, John M Skibber, et al.
Obstetric Medicine
|
July 18, 2022
Colorectal cancer during pregnancy or postpartum: Case series and literature review
Jane E Rogers, Terri L Woodard, Graciela Mn Gonzalez, et al.
Targeted Oncology
|
March 27, 2025
A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors
Cathy Eng, Nehal J Lakhani, Philip A Philip, et al.
Annals of Surgical Oncology
|
August 24, 2017
Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial Neoplasm
Tara L Sagebiel, Amr Mohamed, Aurelio Matamoros, et al.
Plos One
|
August 30, 2017
Clinical utility of circulating cell-free DNA in advanced colorectal cancer
Allan A Lima Pereira, Maria Pia Morelli, Michael Overman, et al.
Page
of 32